Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T18:55:35.706Z.
Calculation as of: 2026-10-06T18:55:35.706Z.
Quote observation: 2026-10-06T18:30:59.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 92c64d45da0f6188a1f90128b536bb11be3c3b1eef81eadefd65dadb391e1e70
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Alzamend Neuro Inc
Market Cap
$5.20M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.21M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.23M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.28M
Operating Cash Flow Yield
N/A
TTM Avg
17.61%
3Y Avg
17.61%
5Y Avg
17.61%
Market Cap
$5.12M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.08M
Operating Cash Flow Yield
N/A
TTM Avg
7.23%
3Y Avg
6.60%
5Y Avg
6.60%
Market Cap
$5.34M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.06M
Operating Cash Flow Yield
N/A
TTM Avg
9.00%
3Y Avg
9.00%
5Y Avg
9.00%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alzamend Neuro Inc (ALZN) | $5.20M | N/A | N/A | N/A | N/A |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | N/A | N/A | N/A | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.23M | N/A | N/A | N/A | N/A |
| Pulmatrix, Inc. (PULM)vs › | $5.28M | N/A | 17.61% | 17.61% | 17.61% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.12M | N/A | N/A | N/A | N/A |
| Soligenix, Inc. (SNGX)vs › | $5.31M | N/A | N/A | N/A | N/A |
| Imunon, Inc. (IMNN)vs › | $5.08M | N/A | 7.23% | 6.60% | 6.60% |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.34M | N/A | N/A | N/A | N/A |
| Xenetic Biosciences, Inc. (XBIO)vs › | $5.06M | N/A | 9.00% | 9.00% | 9.00% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.06M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
